Helen Bunch, Non Executive Director, bought 1,103 shares in the company on the 11th November 2019 at a price of 269.14p. The Director now holds...

Simon Hayes, Non Executive Director, has re-invested 328 shares in the company on the 8th November 2019 at a price of 888.20p. The Director now...

Caner and neurological-condition focused Evgen Pharma said a trial of a treatment for subarachnoid haemorrhage, a type of stroke, had failed to achieve its primary...

Events group Arena Events said it had agreed to a new £2m debt facility, having recently been awarded a number of new contracts across its...

InfraStrata said it would raise £6.0m from a share issue to fund the acquisition of troubled Irish shipyard Harland & Wolff from administrators.

New shares...

Cyber security and intelligence services provider Falanx said its revenue had grown by about 20% in the first half of its financial year.

In a...

Animal pharmaceuticals company Eco Animal Health warned of a lower first-half profit and a full-year result potentially significantly below market forecasts.

The company blamed the...

Robert Fenwick, Non Executive Director, sold 110,549 shares in the company on the 11th November 2019 at a price of 576.38p. The Director now holds...

Sir Roger Bone, Non Executive Director, bought 135 shares in the company on the 8th November 2019 at a price of 733.26p. The Director now...

Clive Adamson, Non Executive Director, bought 1,066 shares in the company on the 11th November 2019 at a price of 490.20p. The Director now holds...